RecruitingNot ApplicableNCT06420115

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

AOP2780 - Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?


Sponsor

University Hospital Padova

Enrollment

580 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two different biopsy needle sizes to see whether a thinner needle can detect prostate cancer just as well — or better — while causing fewer side effects. Biopsies are done through the perineum (the area between the legs) using MRI guidance. **You may be eligible if...** - You have a raised PSA (prostate-specific antigen) blood test or an abnormal prostate exam suggesting cancer - An MRI scan shows at least one suspicious area in your prostate (rated PI-RADS 3 or higher) **You may NOT be eligible if...** - You are already on active surveillance for prostate cancer, or you have been previously diagnosed with prostate cancer - You have previously had radiotherapy to your prostate for cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEdifferent needle size for prostate biopsy

MRI Fusion Transperineal Prostate Biopsy


Locations(1)

Urology Unit - Padua University Hospital

Padua, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06420115


Related Trials